Latest News
News
Closed-loop insulin control for T2DM is feasible in hospital setting
ORLANDO – Noncritical patients tolerated automated devices and had fewer clinically significant hypoglycemic events.
Conference Coverage
Meet the rare diabetes diagnosis that thrills patients
When appropriate, endocrinologists should test for rare monogenetic form, experts say.
From the Journals
IVF linked to slight increase in risk of some cancers
A large observational study found no increase in risk for uterine cancer, but small increases in risk of some breast and ovarian cancers in women...
From the Journals
New hypertension guidelines would add 15.6 million new diagnoses
A new analysis estimates that adopting the 2017 ACC/AHA hypertension guidelines would add 15 million Americans to the ranks of the hypertensives,...
News
Fluoroquinolones can cause fatal hypoglycemia, FDA warns
Video
RISE: Insulin glargine, metformin offer no beta cell function benefit in youth
ORLANDO – Findings from pediatric portions of RISE, a T2DM medication study, are disappointing but lay strong foundation for future studies in...
Feature
What might Kavanaugh confirmation mean for ACA, abortion access?
Judge Brett M. Kavanaugh was nominated to the Supreme Court by President Trump on July 9.
Conference Coverage
Prolia tops risedronate at 2 years in steroid-induced osteoporosis
Conference Coverage
CANVAS data: Canagliflozin generally well tolerated up to 6.5 years
The longest-term safety data to date show that canagliflozin is generally well tolerated for up to 6.5 years in patients with T2DM and high CV...
From the Journals
Treat chronic endometritis to improve implantation rates
Could chronic endometritis be a reversible factor of infertility?
Conference Coverage
Uric acid tied to pediatric diabetic kidney disease
ORLANDO – A new indication for allopurinol?